Actinogen's Trial Validates Xanamem for Alzheimer's, Showcasing Consistent Effectiveness Actinogen Medical's Xanamem shows promising results in recent trials, maintaining therapeutic blood levels in both fed and fasted states, crucial for Alzheimer's treatment.

Actinogen's Trial Validates Xanamem for Alzheimer's, Showcasing Consistent Effectiveness #Australia #Sydney #Alzheimer's #Xanamem #Actinogen

Actinogen Medical's Innovative Alzheimer's Trial Now Recruiting Participants in the US Actinogen Medical's new trial invites individuals with Alzheimer's to explore a promising treatment that may slow cognitive decline, changing the therapeutic landscape.

Actinogen Medical's Innovative Alzheimer's Trial Now Recruiting Participants in the US #United_States #Various #Alzheimer's_Disease #Xanamem #Actinogen

Actinogen Medical Publishes Key Clinical Pharmacology Insights on Xanamem Actinogen Medical Limited has published an important peer-reviewed article detailing the clinical pharmacology of Xanamem, targeting Alzheimer's and depression.

Actinogen Medical Publishes Key Clinical Pharmacology Insights on Xanamem #Australia #Sydney #Actinogen_Medical #Xanamem #Emestedastat

Actinogen Medical Introduces New Nonproprietary Name for Xanamem: Emestedastat Actinogen Medical has unveiled 'emestedastat' as the new nonproprietary name for its Alzheimer's treatment, Xanamem. This strategic move is secured by the WHO's recognition and signifies a pioneering step in drug identification.

Actinogen Medical Introduces New Nonproprietary Name for Xanamem: Emestedastat #Australia #Sydney #Actinogen_Medical #Xanamem #Emestedastat

Actinogen boosts trial with Cambridge Cognition's digital suite - PharmaTimes Partnership aims to advance Alzheimer's research with innovative tools

#digitalneuroscience #brainhealth #Actinogen #ActinogenMedical #neuropsychiatricdiseases #CambridgeCognition #emestedastat #Xanamem #CANTABAttention #Alzheimersresearch #AlzheimersDisease #XanaMIAclinicaltrail #dementia #plasmabiomarker #biomarker #pTau181
pharmatimes.com/news/actinog...

Actinogen Medical Advances in Alzheimer’s Research with US Trial Launch Actinogen Medical has commenced its groundbreaking Alzheimer’s trial in the US, marking a significant milestone in the fight against dementia. Set to yield results by 2026.

Actinogen Medical Advances in Alzheimer’s Research with US Trial Launch #United_States #Sydney #Alzheimer's_Disease #Actinogen_Medical #Xanamem